Study of LMP1- and LMP2- Specific Cytotoxic T-Lymphocytes (CTL)

NCT00515957 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Conditions

NASOPHARYNGEAL CARCINOMA

Interventions

GENETIC: genetically modified CTLs in combo with CD45 antibodies

Sponsor

Baylor College of Medicine

Collaborators

[object Object]
[object Object]